Health News Releases

  • Today November 13
October 29, 2016 03:00
Face the Facts: Stroke is Treatable
Every two seconds, someone in the world is having a stroke. Globally, stroke is the leading cause of disability and the second leading cause of death. The right stroke care can save lives, but glob
October 27, 2016 11:15
Boehringer Ingelheim’s adalimumab biosimilar candidate shows similar efficacy and safety profile to Humira® in pivotal Phase III study
Boehringer Ingelheim today announced top-line results from the pivotal Phase III clinical study of BI 695501, a biosimilar candidate to U.S.-licensed Humira® and EU approved Humira® (adalimumab). BI 6
October 25, 2016 13:30
Q2 Solutions Enhances Companion Diagnostics Capabilities in Collaboration with Illumina
Q2 Solutions, a global clinical trials laboratory services organization, today announced the expansion of its genomic companion diagnostics (CDx) capabilities. This comes as a result of an agreement b
October 19, 2016 17:55
World Federation of Societies of Anaesthesiologists (WFSA) Signs Commitment to Support Patient Safety Movement’s Mission of Zero Patient Deaths by 2020
The World Federation of Societies of Anaesthesiologists (WFSA) has signed a commitment to action and announced that it will support the Patient Safety Movement Foundation (PSMF) and its mission to eli
October 19, 2016 13:50
QuintilesIMS Wins Society for Clinical Research Sites’ 2016 Eagle Award
QuintilesIMS (NYSE:Q) announced today that it has been awarded the 2016 Eagle Award from the Society for Clinical Research Sites (SCRS) for the fourth consecutive year. Presented during the annual SCR
October 19, 2016 10:05
Takeda Showcases Continued Commitment in Hodgkin Lymphoma During 10th International Symposium on Hodgkin Lymphoma (ISHL)
Takeda Pharmaceutical Company Limited (TSE: 4502) will present data on ADCETRIS® (brentuximab vedotin) in Hodgkin lymphoma at the 10th International Symposium on Hodgkin Lymphoma (ISHL), October 22 -
October 17, 2016 11:15
Oral GED-0301 Phase 1b Results Show Clinical Remission and Endoscopic Response at Week 12 in Patients with Active Crohn’s Disease
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that data from a randomized, double-blind, multicenter, exploratory phase 1b study evaluati
October 14, 2016 17:55
QuintilesIMS Named 2016 Frost & Sullivan Asia Pacific CRO Company of the Year
QuintilesIMS today was named Asia Pacific Contract Research Organization (CRO) Company of the Year by Frost & Sullivan, a leading business research and consulting firm, because of its industry leaders
October 14, 2016 11:20
Celgene to Present New Data on Investigational Compounds at UEGW and ACG Congresses
Celgene Corporation (NASDAQ:CELG) today announced that findings from clinical trials of investigational compounds GED-0301 (mongersen), ozanimod and RPC4046 will be presented at the United European Ga
October 12, 2016 10:00
Mannatech’s Asia MannaFest℠ Event Fuels Company Momentum
Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, is hosting its annual Asia MannaFest event at Olympic Park Handbal
October 11, 2016 17:25
Zymergen Announces $130 Million in Series B Funding, Led by SoftBank
Zymergen, a technology company unlocking the power of biology, announced today that it has raised 130 million USD in Series B funding led by SoftBank Group (TOKYO: 9984). The round also includes prior
October 11, 2016 10:50
Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m
Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody®-based therapeutics, and Takeda Pharmaceutical Company Limited (TSE: 4502) today announced a global, strategic, mu
October 11, 2016 10:45
Durvalumab Shows Promising Preliminary Early Data in Lung and Head & Neck Cancers
AstraZeneca and its global biologics research and development arm, MedImmune, announced today efficacy and safety data for durvalumab from two separate cohorts of patients with either advanced non-sma
October 10, 2016 09:30
Faslodex Demonstrates Progression-Free Survival Advantage in 1st Line Advanced Breast Cancer
AstraZeneca today announced data from the Phase III FALCON trial demonstrating superior median progression-free survival (PFS) for Faslodex (fulvestrant) 500mg compared to Arimidex (anastrozole) 1mg i
October 07, 2016 13:55
Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter®
Masimo (NASDAQ: MASI) announced today the CE marking of the Rad-97™ Pulse CO-Oximeter®. Rad-97 offers the same Measure-through Motion and Low Perfusion™ SET® pulse oximetry and upgradeable rainbow SET
October 06, 2016 15:35
Herbalife Nutrition Asia Pacific Survey Reveals That Millennials Find It Difficult to Engage in Physical Activities in the Modern Workplace
Herbalife Nutrition, a global nutrition company, has released findings from its Asia Pacific Millennials At Work Survey[1], showing that younger workers in Asia want to do more physical exercise while
October 05, 2016 18:00
Cardinal Health Expands in Asia
Leading global, integrated healthcare services and products company, Cardinal Health (NYSE:CAH), today announced that it will bring its powder-free gloves product line to Hong Kong while further penet
October 05, 2016 16:00
IncellDx’s Quantitative Immuno-Oncology Assay OncoTect iO Published in New Study
IncellDx, Inc., a single cell, precision medicine company, today announced that the international peer-reviewed medical journal Cancer Immunology, Immunotherapy has published a manuscript entitled: “Q
October 04, 2016 21:00
Replicor to Disclose Late Breaking HBV Clinical Data at AASLD 2016
Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic hepatitis B and D patients, today announced that the preliminary interim analysis from its latest REP 401 clinica
October 04, 2016 13:50
QuintilesIMS: Merger Creates a Leading Global Integrated Information and Technology-Enabled Healthcare Service Provider
Quintiles IMS Holdings, Inc. (NYSE:Q) today announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdi
October 04, 2016 11:45
Samsung Bioepis' Marketing Authorization Application for SB3 Trastuzumab Biosimilar Candidate Accepted for Review by the European Medicines Agency
Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA) has accepted for review the company’s Marketing Authorization Application (MAA) for SB3, a biosimilar candidate refer
September 30, 2016 09:45
Boehringer Ingelheim and Sarah Cannon Research Institute launch strategic collaboration to develop novel immune-oncology therapies
Boehringer Ingelheim and Sarah Cannon Research Institute, the research arm of Sarah Cannon, the global cancer institute of HCA, announced today a new strategic collaboration. This partnership brings t
September 29, 2016 11:50
Boehringer Ingelheim Boosts Immune-Oncology Pipeline Through Collaboration with ViraTherapeutics
Boehringer Ingelheim and ViraTherapeutics today announced a long term collaboration to jointly develop a next generation oncolytic virus therapy platform and to investigate ViraTherapeutic’s lead cand
September 27, 2016 13:35
Herbalife Nutrition and Special Olympics Announce $1 Million Fitness Collaboration
Herbalife (NYSE: HLF), a global nutrition company, today announced a $1 million collaboration with Special Olympics to support the organization’s fitness programming around the world, focusing on incr
September 23, 2016 19:30
Alexion Employees Volunteer Together in Company’s First Global Day of Service
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that more than 1,500 employees around the world are volunteering in their respective communities as part of the Company’s first Global Day o
25 per page50 per page75 per page100 per page